Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–28.
Kelly T, Yang W, Chen C-S, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32(9):1431–7.
Oliveira JS, Pinheiro MB, Fairhall N, Walsh S, Franks TC, Kwok W, et al. Evidence on physical activity and the prevention of frailty and sarcopenia among older people: a systematic review to inform the World Health Organization physical activity guidelines. J Phys Activity Health. 2020;17(12):1247–58.
Kong Z, Fan X, Sun S, Song L, Shi Q, Nie J. Comparison of high-intensity interval training and moderate-to-vigorous continuous training for cardiometabolic health and exercise enjoyment in obese young women: a randomized controlled trial. PLoS ONE. 2016;11(7):e0158589.
Delfan M, Vahed A, Bishop DJ, Amadeh Juybari R, Laher I, Saeidi A, et al. Effects of two workload-matched high intensity interval training protocols on regulatory factors associated with mitochondrial biogenesis in the soleus muscle of diabetic rats. Front Physiol. 2022;13:927969.
Boyd JC, Simpson CA, Jung ME, Gurd BJ. Reducing the intensity and volume of interval training diminishes cardiovascular adaptation but not mitochondrial biogenesis in overweight/obese men. PLoS ONE. 2013;8(7):e68091.
Shanaki M, Khosravi M, Khoshdooni-Farahani A, Dadashi A, Heydari MF, Delfan M et al. High-intensity interval training reversed high-fat diet–induced M1-macrophage polarization in rat adipose tissue via inhibition of NOTCH signaling. J Inflamm Res. 2020:165–74.
Alahmadi M. High-intensity interval training and obesity. J Nov Physiother. 2014;4(3):211.
Lee T, Yun S, Jeong JH, Jung TW. Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation. Mol Cell Endocrinol. 2019;486:96–104.
Li E, Shan H, Chen L, Long A, Zhang Y, Liu Y, et al. OLFR734 mediates glucose metabolism as a receptor of asprosin. Cell Metabol. 2019;30(2):319–28.e8.
Nakamura K, Fuster JJ, Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol. 2014;63(4):250–9.
Al-Daghri NM, Alokeel RM, Alamro A, Ansari MG, Hussain SD, Amer OE, et al. Serum asprosin levels are associated with obesity and insulin resistance in arab adults. J King Saud University-Science. 2022;34(1):101690.
Shabir K, Brown JE, Afzal I, Gharanei S, Weickert MO, Barber TM, et al. Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: comprehensive review of preclinical and clinical evidence. Cytokine Growth Factor Rev. 2021;60:120–32.
Wen X, Su B, Gao M, Chen J, Zhou D, You H, et al. Obesity-associated up-regulation of lipocalin 2 protects gastric mucosa cells from apoptotic cell death by reducing endoplasmic reticulum stress. Cell Death Dis. 2021;12(2):221.
Kumar S, Mankowski RT, Anton SD, Babu Balagopal P. Novel insights on the role of spexin as a biomarker of obesity and related cardiometabolic disease. Int J Obes. 2021;45(10):2169–78.
Yang R-Z, Lee M-J, Hu H, Pray J, Wu H-B, Hansen BC, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J physiology-endocrinology Metabolism. 2006;290(6):E1253–E61.
de Souza Batista CM, Yang R-Z, Lee M-J, Glynn NM, Yu D-Z, Pray J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007;56(6):1655–61.
Rothermel J, Lass N, Barth A, Reinehr T. Link between omentin-1, obesity and insulin resistance in children: findings from a longitudinal intervention study. Pediatr Obes. 2020;15(5):e12605.
Chen N, Li Q, Liu J, Jia S. Irisin, an exercise-induced myokine as a metabolic regulator: an updated narrative review. Diab/Metab Res Rev. 2016;32(1):51–9.
Arhire LI, Mihalache L, Covasa M. Irisin: a hope in understanding and managing obesity and metabolic syndrome. Front Endocrinol. 2019;10:524.
Tun S, Spainhower CJ, Cottrill CL, Lakhani HV, Pillai SS, Dilip A, et al. Therapeutic efficacy of antioxidants in ameliorating obesity phenotype and associated comorbidities. Front Pharmacol. 2020;11:1234.
DiNicolantonio JJ, Bhat AG, OKeefe J. Effects of spirulina on weight loss and blood lipids: a review. Open Heart. 2020;7(1):e001003.
Khalafi M, Symonds ME. The impact of high-intensity interval training on inflammatory markers in metabolic disorders: a meta-analysis. Scand J Med Sci Sports. 2020;30(11):2020–36.
Golestani F, Mogharnasi M, Erfani-Far M, Abtahi-Eivari SH. The effects of spirulina under high-intensity interval training on levels of nesfatin-1, omentin-1, and lipid profiles in overweight and obese females: a randomized, controlled, single-blind trial. J Res Med Sciences: Official J Isfahan Univ Med Sci. 2021;26.
Nathanson V. Revising the declaration of Helsinki. British Medical Journal Publishing Group; 2013.
Ceylan Hİ, Saygın Ö, Özel Türkçü Ü. Assessment of acute aerobic exercise in the morning versus evening on asprosin, spexin, lipocalin-2, and insulin level in overweight/obese versus normal weight adult men. Chronobiol Int. 2020;37(8):1252–68.
Thomas S, Reading J, Shephard RJ. Revision of the physical activity readiness questionnaire (PAR-Q). Canadian journal of sport sciences. 1992.
Ghroubi S, Elleuch H, Chikh T, Kaffel N, Abid M, Elleuch M. Physical training combined with dietary measures in the treatment of adult obesity. A comparison of two protocols. Annals Phys Rehabilitation Med. 2009;52(5):394–413.
Hunter GR, Byrne NM, Sirikul B, Fernández JR, Zuckerman PA, Darnell BE, et al. Resistance training conserves fat-free mass and resting energy expenditure following weight loss. Obesity. 2008;16(5):1045–51.
Thompson WR, Gordon NF, Pescatello LS. ACSM’s guidelines for exercise testing and prescription. Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010.
Myers J, Forman D, Balady G, Franklin B, Nelson-Worel J, Martin B, on behalf of the American Heart Association Subcommittee on Exercise., Cardiac Rehabilitation, and Prevention of the Council on Clinical Cardiology, Council on Lifestyle and Cardiometabolic Health, Council on Epidemiology and Prevention, and Council on Cardiovascular and Stroke Nursing. Supervision of exercise testing by nonphysicians: a scientific statement from the American Heart Association [published online ahead of print Aug. 18, 2014]. Circulation. 2009.
Soltani M, Aghaei Bahmanbeglou N, Ahmadizad S. High-intensity interval training irrespective of its intensity improves markers of blood fluidity in hypertensive patients. Clin Exp Hypertens. 2020;42(4):309–14.
Mazokopakis EE, Papadomanolaki MG, Fousteris AA, Kotsiris DA, Lampadakis IM, Ganotakis ES. The hepatoprotective and hypolipidemic effects of spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study. Annals Gastroenterology: Q Publication Hellenic Soc Gastroenterol. 2014;27(4):387.
Thomas DT, Erdman KA, Burke LM. Position of the academy of nutrition and dietetics, dietitians of Canada, and the American College of Sports Medicine: nutrition and athletic performance. J Acad Nutr Dietetics. 2016;116(3):501–28.
Hernández-Lepe MA, Wall-Medrano A, López-Díaz JA, Juárez-Oropeza MA, Luqueño-Bocardo OI, Hernández-Torres RP, et al. Hypolipidemic effect of Arthrospira (Spirulina) maxima supplementation and a systematic physical exercise program in overweight and obese men: a double-blind, randomized, and crossover controlled trial. Mar Drugs. 2019;17(5):270.
Braith RW, Stewart KJ. Resistance exercise training: its role in the prevention of cardiovascular disease. Circulation. 2006;113(22):2642–50.
Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third national health and nutrition examination survey. J Clin Endocrinol Metabolism. 2011;96(9):2898–903.
Batrakoulis A, Jamurtas AZ, Metsios GS, Perivoliotis K, Liguori G, Feito Y, et al. Comparative efficacy of 5 exercise types on cardiometabolic health in overweight and obese adults: a systematic review and network meta-analysis of 81 randomized controlled trials. Circulation: Cardiovasc Qual Outcomes. 2022;15(6):e008243.
Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol. 2012;2(2):1143.
Gurney T, Spendiff O. Algae supplementation for exercise performance: current perspectives and future directions for spirulina and chlorella. Front Nutr. 2022:384.
Nedeva IS, Assyov Y, Karamfilova V, Vodenicharov V, Gerganova A, Hristova J, et al. Circulating asprosin concentrations in patients with obesity and carbohydrate disturbances. Horm Metab Res. 2023;55(4):284–9.
Yuan M, Li W, Zhu Y, Yu B, Wu J. Asprosin: a novel player in metabolic diseases. Front Endocrinol (Lausanne). 2020;11:64.
Szulinska M, Gibas-Dorna M, Miller-Kasprzak E, Suliburska J, Miczke A, Walczak-Gałezewska M, et al. Spirulina maxima improves insulin sensitivity, lipid profile, and total antioxidant status in obese patients with well-treated hypertension: a randomized double-blind placebo-controlled study. Eur Rev Med Pharmacol Sci. 2017;21(10):2473–81.
Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic inflammation. Clin Chim Acta. 2010;411(11–12):785–93.
Golestani F, Mogharnasi M, Erfani-Far M, Abtahi-Eivari SH. The effects of spirulina under high-intensity interval training on levels of nesfatin-1, omentin-1, and lipid profiles in overweight and obese females: a randomized, controlled, single-blind trial. J Res Med Sci. 2021;26:10.
DeMarco VG, Johnson MS, Whaley-Connell AT, Sowers JR. Cytokine abnormalities in the etiology of the cardiometabolic syndrome. Curr Hypertens Rep. 2010;12(2):93–8.
Otani H. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal. 2011;15(7):1911–26.
Kolodziejski PA, Pruszynska-Oszmalek E, Micker M, Skrzypski M, Wojciechowicz T, Szwarckopf P, et al. Spexin: a novel regulator of adipogenesis and fat tissue metabolism. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(10):1228–36.
Pruszynska-Oszmalek E, Sassek M, Szczepankiewicz D, Nowak KW, Kolodziejski PA. Short-term administration of spexin in rats reduces obesity by affecting lipolysis and lipogenesis: an in vivo and in vitro study. Gen Comp Endocrinol. 2020;299:113615.
Lv S, Zhou Y, Feng Y, Zhang X, Wang X, Yang Y. Peripheral spexin inhibited food intake in mice. Int J Endocrinol. 2020;2020:4913785.
留言 (0)